National Quality Forum
ESRD Quality Measures Steering Committee
January 11-12, 2011
Measure Review Outcomes
The ESRD Steering Committee for the National Quality Forum met in Washington, DC on January 11-12, 2011 to recommend measures for possible endorsement. The measures they reviewed were submitted to NQF in response to a call for measures in fall 2010.
NQF will make public a draft report for review and comment in March 2011. Once the commenting and member voting periods conclude, the NQF Consensus Standards Approval Committee (CSAC) will meet on June 17, 2011. During this meeting, the CSAC is expected to consider endorsement of End Stage Renal Disease measures.
To see the measures in their entirety, visit the NQF End Stage Renal Diseasepage.
Dialysis Adequacy and Nutrition
Measure / Measure Developer / Status1418 Frequency of Adequacy Measurement for Pediatric Hemodialysis Patients / CMS / Recommended for Endorsement
1421 Method of Adequacy Measurement for Pediatric Hemodialysis Patients / CMS / Recommended for Endorsement
1423 Minimum spKt/V for Pediatric Hemodialysis Patients / CMS / Recommended for Endorsement
1425 Measurement of nPCR for Pediatric Hemodialysis Patients / CMS / Recommended for Endorsement
Anemia
Measure / Measure Developer / Status1426 Assessment of Iron Stores / CMS / Not recommended
1431 Measurement of Iron Stores for Pediatric Patients / CMS / Not recommended
1428 Use of Iron Therapy When Indicated / CMS / Not recommended
1433 Use of Iron Therapy for Pediatric Patients / CMS / Recommended for time-limited endorsement
1424 Monthly Hemoglobin Measurement for Pediatric Patients / CMS / Recommended for Endorsement
1430 Lower Limit of Hemoglobin for Pediatric Patients / CMS / Recommended for time-limited endorsement
1429 Avoidance of Iron Therapy in Iron Overload / CMS / Not recommended
Fluid Weight Management
Measure / Measure Developer / Status1432 Dietary Sodium Reduction Advice / CMS / Not recommended
1434 Sodium Profiling Practice for Hemodialysis / CMS / Not recommended
1435 Restriction of Dialysate Sodium / CMS / Not recommended
1437 Utilization of Dialysis Duration of Four Hours or Longer for Patients New to Dialysis / CMS / Not recommended
1439 Utilization of High Ultrafiltration Rate for Fluid Removal / CMS / Not recommended
1438 Periodic Assessment of Post-Dialysis Weight by Nephrologist / CMS / Recommended for time-limited endorsement
Mineral Metabolism
Measure / Measure Developer / Status1454 Proportion of patients with hypercalcemia / CMS / Recommended for Endorsement
1427 Adult dialysis patients - serum phosphorus greater than 6 mg/dl / Genzyme / Not recommended
1461 Proportion of patients with hypophosphatemia / CMS / Not recommended
Hospitalization
Measure / Measure Developer / Status1463 Standardized Hospitalization Ratio for Admissions / CMS / Recommended for Endorsement
1464 Standardized Hospitalization Ratio for Days / CMS / Not recommended
Infection
Measure / Measure Developer / Status1477 National Healthcare Safety Network (NHSN) Intravenous (IV) Antibiotic Start Measure / NHSN/CDC / Not recommended
1460 National Healthcare Safety Network (NHSN) Bloodstream Infection Measure / NHSN/CDC / Recommended for Endorsement
1478 National Healthcare Safety Network (NHSN) Vascular Access-Related Bloodstream Infection Measure / NHSN/CDC / Not recommended
1456 Bacteremia (rate) / CMS / Not recommended
1457 Access-related Bacteremia (rate) [stratified by access] / CMS / Recommended for time-limited endorsement
1455 Access-related Bacteremia – using Medicare claims (rate) [stratified by access] / CMS / Not recommended
1449 Unavailable Blood Culture Results (percentage) / CMS / Not recommended
1453 Clinically Confirmed Infection (rate) / CMS / Withdrawn
1469 Clinically Confirmed Access-related Infection (rate) [stratified by access] / CMS / Not recommended
1450 Unavailable Clinical Confirmation (percentage) / CMS / Withdrawn